Trump administration drug deals included overseas price hikes, tariff protection
Confidential agreements with Pfizer and Eli Lilly also contained broad confidentiality clauses, documents show.
AI-assisted coverage comparison, editor-supervised · How this was made
Trump administration drug deals included overseas price hikes, tariff protection
Photograph: Joe.My.God. (embedded from source)
What this story says
- The Trump administration made confidential agreements with pharmaceutical companies Pfizer and Eli Lilly.
- These deals included inducements for companies to increase drug prices in other countries.
- The agreements also provided protection for the companies against potential tariffs imposed by President Donald Trump.
- The documents were secured through Freedom of Information Act lawsuits and contained broad confidentiality provisions.
Who covered it
Percentages are shares of the 6 outlets carrying a published leaning rating. 1 of the 7 outlets we know ran this story carry no rating and are not counted in them. Coverage measured .
Trust
60/100
Craft
65/100
Hype
45/100
7 sources · methodology
Thin on the right so far
None of the 6 outlets with a published leaning rating that ran this story are rated right.
This story is still being watched, so it is a count and not yet a finding. Coverage keeps arriving for hours after an event, and a side that has published nothing this morning may publish by tonight. If it is still true when we stop checking, we will say so plainly.
Confidential agreements between the Trump administration and pharmaceutical companies Pfizer and Eli Lilly included terms that encouraged overseas price increases and offered protection from tariffs, according to documents obtained through Freedom of Information Act lawsuits. The Health and Human Services Department (HHS) also agreed to broad confidentiality provisions within these deals.
The documents detail negotiations that led to voluntary U.S. price cuts by both companies. However, the full text of the agreements revealed undisclosed commitments from the administration, such as how disputes would be handled. In its agreement with Pfizer, HHS pledged to treat confidential information as exempt from Freedom of Information Act (FOIA) requests and to limit access to necessary government personnel.
Disagreement on overseas pricing
Joe.My.God. and The Washington Post report that the deals included inducements to raise drug prices overseas. Citizen.org and Political Wire do not mention overseas pricing in their digests. Protect Our Care's digest does not mention overseas pricing.
What the coverage left out
None of the left-rated or centre-rated reports printed below mention specific figures for the voluntary U.S. price cuts agreed upon by Pfizer and Eli Lilly. The Protect Our Care digest mentions that the deals 'do nothing to lower costs for seniors and working families' and 'pad the pockets of big drug companies', but does not provide specific details on the price cuts themselves or their impact.
Still developing. We have re-checked which outlets are covering this 6 times, most recently on 20 Sept 2026, 01:15, and will add the sides that appear.
How each side covered it
Our own reading of the reporting listed below, written from the outlets’ articles rather than quoted from them. The reasoning is set out on our methodology page.
Left
3 rated outlets
- Reports from Joe.My.God., citizen.org, and The Washington Post highlighted the confidential nature of the deals and their terms. Joe.My.God. and The Washington Post, which published full reports, detailed that the agreements included inducements for companies to raise drug prices overseas and promised protection from President Donald Trump's tariffs. They also noted the broad confidentiality provisions within the documents, with The Washington Post quoting HHS's pledge to treat information as exempt from FOIA. Citizen.org's digest also mentioned the deals favouring big pharma over patients.
Centre
3 rated outlets
- Political Wire's digest focused on the secret contracts and their terms, citing The Washington Post. It reported that the deals included inducements to raise drug prices overseas and promised tariff protection. The digest also noted the broad confidentiality clauses.
Right
0 rated outlets
No outlet rated right has run this story so far. We are still checking, and will say plainly if that does not change.
Questions about this coverage
- How did the left and right cover Trump administration drug deals included overseas price hikes, tariff…?
- Of the 6 outlets on this story carrying a published leaning rating, 50% are rated left, 50% are rated centre, 0% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 7. The sections above set out what each side emphasised, in its own terms.
- Is Trump administration drug deals included overseas price hikes, tariff… left or right?
- Too few of the outlets on this story carry a published leaning rating to say. 6 of them do, and this site does not characterise a field under 12: at that size one newsroom filing moves the share by ten points. The percentages above are the count as it stands.
- Is the coverage of Trump administration drug deals included overseas price hikes, tariff… biased?
- Trump administration drug deals included overseas price hikes, tariff protection is one event reported by 7 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.
- Which side is not reporting Trump administration drug deals included overseas price hikes, tariff…?
- When we first saw this story, outlets rated right had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.
- Which outlets covered Trump administration drug deals included overseas price hikes, tariff…?
- 7 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.
- What were the main terms of the secret drug pricing deals?
- The confidential deals between the Trump administration and pharmaceutical companies Pfizer and Eli Lilly included inducements for companies to raise drug prices overseas and promised protection from President Donald Trump's tariffs. The agreements also contained broad confidentiality provisions, with HHS pledging to exempt information from FOIA requests.
- How were these deal terms revealed?
- The terms of the confidential drug pricing deals were revealed through documents obtained by news outlets via Freedom of Information Act (FOIA) lawsuits. These documents detailed negotiations and undisclosed commitments made by the administration.
- Did the deals lower drug prices in the US?
- The companies agreed to voluntary U.S. price cuts as part of the deals. However, the coverage does not specify the exact figures for these reductions or their overall impact on costs for consumers.
Read it at the source
7 outlets, grouped by the leaning a published rating gives them. Every headline links to the original; an underlined outlet name opens our profile of that publisher.
Left
3- Trump’s Drug Pricing Deals Favor Big Pharma Over Patients, Public Citizen FOIA Finds - Public Citizen (opens citizen.org in a new tab)
citizen.org — is citizen.org biased? Our profile of this outlet
- Secret Drug Pricing Deals Include Tariff Protections (opens Joe.My.God. in a new tab)
Joe.My.God. — is Joe.My.God. biased? Our profile of this outlet
- Secret contracts reveal undisclosed terms in Trump’s drug-pricing deals (opens The Washington Post in a new tab)
The Washington Post — is The Washington Post biased? Our profile of this outlet
Centre
3- Secret contracts reveal undisclosed terms in Trump’s drug-pricing deals (opens INTELLINEWS in a new tab)
INTELLINEWS — is INTELLINEWS biased? Our profile of this outlet
- Secret Contracts Reveal Terms in Drug-Pricing Deals (opens Political Wire in a new tab)
Political Wire — is Political Wire biased? Our profile of this outlet
- Protect Our Care: Confirmed: Trump’s secret deals pad the pockets of big drug companies while raising costs for seniors (opens Wispolitics.com in a new tab)
Wispolitics.com — is Wispolitics.com biased? Our profile of this outlet
Right
0No outlet in this group ran the story.
Not rated
1How did this read?
About the coverage, not about the story. We do not ask whether you agree with what happened — we have no honest use for that answer.
